s6y
Company name or ticker
Search
Spero Therapeutics, Inc.
8-K
Current report filing
Filed
Tuesday, July 17, 2018
Period
Jul 17, 2018
Accession number
0001193125-18-219722
Documents
8-K
8-K
EX-3.1
EX-3.1
On sec.gov
Filing index
All files
Complete submission text
SGML header